Physidia

The Physidia S3 system has demonstrated strong results in clinical use for intensive home hemodialysis. Studies show improved patient perception and reduced treatment burden with more frequent short-duration sessions. Cardiac features tended to improve over time and the device offers an effective bridge to kidney transplantation. The device was CE-marked and introduced in Europe in 2013; it has been adopted successfully by patients at home with satisfactory outcomes over two years of follow-up. The most prominent findings are as follows... patient perception was improved, while treatment burden was reduced despite a more frequent treatment schedule; secondly, cardiac features tended to improve over time... thirdly, home treatment based on the S3 system offers the best bridging solution to kidney transplantation.